Rock Springs Capital Management LP Q3 2016 Filing

Filed November 14, 2016

Portfolio Value

$1.6B

Holdings

137

Report Date

Q3 2016

Filing Type

13F-HR

All Holdings (137 positions)

#	Stock	Shares	Value	% Portfolio
101	OTICEUROTONOMY INC	210,000	$3.8M	0.24%
102	—CARDIOME PHARMA CORP	1,200,000	$3.8M	0.24%
103	INVAINNOVIVA INC	336,900	$3.7M	0.23%
104	PRGOPERRIGO CO PLC	37,900	$3.5M	0.22%
105	AGLEUSDAEGLEA BIOTHERAPEUTICS INC	524,089	$3.4M	0.21%
106	MDMEDNAX INC	50,000	$3.3M	0.21%
107	—NABRIVA THERAPEUTICS AG	426,000	$3.0M	0.19%
108	—STERIS PLC	40,000	$2.9M	0.18%
109	ITCIEURINTRA CELLULAR THERAPIES INC	190,000	$2.9M	0.18%
110	—CIDARA THERAPEUTICS INC	250,000	$2.9M	0.18%
111	ASMBASSEMBLY BIOSCIENCES INC	390,000	$2.8M	0.18%
112	MCRB1EURSERES THERAPEUTICS INC	220,000	$2.7M	0.17%
113	—DBV TECHNOLOGIES S A	73,000	$2.7M	0.17%
114	TTPHEURTETRAPHASE PHARMACEUTICALS I	662,500	$2.5M	0.16%
115	—GENOCEA BIOSCIENCES INC	480,000	$2.5M	0.15%
116	SCYXEURSCYNEXIS INC	635,000	$2.5M	0.15%
117	—EGALET CORP	300,000	$2.3M	0.14%
118	GBTUSDGLOBAL BLOOD THERAPEUTICS IN	98,000	$2.3M	0.14%
119	—AMSURG CORP	32,500	$2.2M	0.14%
120	—DIMENSION THERAPEUTICS INC	271,370	$2.2M	0.14%
121	NVCRNOVOCURE LTD	214,316	$1.8M	0.11%
122	NVAXNOVAVAX INC	852,500	$1.8M	0.11%
123	DVAXDYNAVAX TECHNOLOGIES CORP	165,000	$1.7M	0.11%
124	BHCVALEANT PHARMACEUTICALS INTL	68,600	$1.7M	0.11%
125	EX9EXELIXIS INC	125,000	$1.6M	0.10%
126	—CHIASMA INC	492,500	$1.4M	0.09%
127	—ANTHERA PHARMACEUTICALS INC	450,000	$1.4M	0.09%
128	—ATYR PHARMA INC	433,500	$1.4M	0.09%
129	—BLUEBIRD BIO INC	20,000	$1.4M	0.09%
130	CERNCHFCERNER CORP	20,000	$1.2M	0.08%
131	INSYEURINSYS THERAPEUTICS INC NEW	100,000	$1.2M	0.07%
132	—WRIGHT MED GROUP INC	1,000,000	$1.1M	0.07%
133	MDGLMADRIGAL PHARMACEUTICALS INC	63,000	$799K	0.05%
134	—CERULEAN PHARMA INC	625,000	$654K	0.04%
135	—OREXIGEN THERAPEUTICS INC	165,300	$549K	0.03%
136	INFIQINFINITY PHARMACEUTICALS INC	270,000	$421K	0.03%
137	—ARIAD PHARMACEUTICALS INC	25,000	$342K	0.02%

PreviousPage 2 of 2